The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Vanguard Health Care Etf

NYSE: VHT
Last

(U.S.) $133.64

Today's change-0.19 -0.14%
Updated May 6 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Vanguard Health Care Etf

NYSE: VHT
Last

(U.S.) $133.64

Today's change-0.19 -0.14%
Updated May 6 4:00 PM -4GMT. Delayed by at least 15 minutes.

Vanguard Health Care Etf down (U.S.)$0.19

Vanguard Health Care Etf closed lower Wednesday, dropping (U.S.)$0.19 or 0.14% to (U.S.)$133.64. Shares have lost 1.15% over the last five days, but sit 4.78% below their 52-week high. This security has outperformed the S&P 500 by 16.41% during the last year.

Key company metrics

  • Open(U.S.) $134.54
  • Previous close(U.S.) $133.83
  • High(U.S.) $134.54
  • Low(U.S.) $132.61
  • Bid / Ask-- / --
  • YTD % change+6.41%
  • Volume228,436
  • Average volume (10-day)271,096
  • Average volume (1-month)250,394
  • Average volume (3-month)270,945
  • 52-week range(U.S.) $103.31 to (U.S.) $140.35
  • Beta0.72
  • Trailing P/E5.18×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.29
  • Dividend yield0.96%
  • Trailing EPS(U.S.) $25.80
Updated May 6 4:00 PM -4GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q4/2014Q2/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedFeb 28, 201502/28/2015Aug 31, 201408/31/2014Feb 28, 201402/28/2014Aug 31, 201308/31/2013
Revenue652233573302
Total other revenue--------
Total revenue652233573302
Gross profit--------
Total cost of revenue--------
Total operating expense2111
Selling / general / administrative2111
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income650232572301
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax650232572301
Income after tax650232572301
Income tax, total0000
Net income650232572301
Total adjustments to net income--------
Net income before extra. items650232572301
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items650232572301
Inc. avail. to common incl. extra. items650232572301
Diluted net income650232572301
Dilution adjustment--------
Diluted weighted average shares37292827
Diluted EPS excluding extraordinary itemsvalue per share17.688.1220.3411.32
Dividends per sharevalue per share1.290.001.140.00
Diluted normalized EPSvalue per share17.688.1220.3411.32